Gleamer key facts
- Developer of a radiology technology designed to detect and highlight bone abnormalities.
- Gleamer’s last known valuation is $52.1M (Jul 2023).
- It has raised $39.5M; the latest was Merger/Acquisition in Mar 2026.
- Notable investors include Bpifrance, Kima Ventures, La French Tech, Agoranov, UI Investissement — 21 tracked in total.
- Status: Acquired/Merged (Operating Subsidiary).
Who backs Gleamer
21+Membership and data by Private Market View
- ·The complete investor list: 21 names
- ·Watch Gleamer: the Monday email on marks, rounds and moves
Gleamer funding rounds
No funding rounds for Gleamer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Gleamer valuation
Gleamer's last known valuation is $52.1 million, from Jul 2023. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Gleamer investors
21 investors are on record for Gleamer, including Bpifrance, Kima Ventures, La French Tech and Agoranov. By type, the record holds 5 venture capital firms and 2 private equity firms.
About Gleamer
Developer of a radiology technology designed to detect and highlight bone abnormalities. The company's technology utilizes an artificial intelligence-based assistant that is easy to use, automatically detects lesions on trauma X-rays and provides preliminary data for diagnosis on standard radiography, enabling radiologists to avoid missing tiny lesions and prioritize patients.
- Sector
- Healthcare
- HQ
- Saint-Mandé, France
- Founded
- 2017
- Employees
- 130
- Website
- gleamer.ai/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Gleamer’s last known valuation, Jul 2023. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.